This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethris Gmbh. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Adrian Ter Steege: Innovator in Ciliopathy Treatment
Introduction
Adrian Ter Steege is an accomplished inventor based in Bonn, Germany. He is currently associated with Ethris GmbH, where he focuses on developing innovative solutions for medical challenges. His work primarily revolves around the treatment of ciliopathies, a group of disorders caused by defects in the structure and function of cilia.
Latest Patent Applications
Adrian Ter Steege has made significant contributions through his patent application titled "Treatment of Ciliopathies." This application presents a pharmaceutical composition that includes a polyribonucleotide designed to treat ciliopathies in affected subjects. The composition encodes a functional version of a protein whose defect is linked to the ciliopathy. Furthermore, the application outlines a method for analyzing the effects of the polyribonucleotide on ciliogenesis, which is crucial for understanding and potentially mitigating the impact of these disorders.
Conclusion
Adrian Ter Steege's innovative work at Ethris GmbH highlights his commitment to advancing medical treatments for ciliopathies. His research and patent applications reflect a dedication to improving the lives of those affected by these complex conditions.